Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,598 | 1,767 | 1,896 | 1,925 | 2,021 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 679 |
| Accounts receivable | -62 | 2,383 | -3,075 | 2,058 | 508 |
| Accounts payable and accrued liabilities | -221 | -2,150 | 1,122 | 2,243 | -859 |
| Other Working Capital | 1,130 | -567 | -2,557 | 3,729 | -669 |
| Other Operating Activity | 2,732 | 4,221 | 1,807 | -4,439 | 3,781 |
| Operating Cash Flow | $5,177 | $5,654 | $-807 | $5,516 | $5,461 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54 | -44 | -13 | -102 | -2 |
| Purchase Sale Intangibles | 0 | 0 | -23 | -65 | -197 |
| Investing Cash Flow | $-54 | $-44 | $-36 | $-167 | $-199 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,283 | -3,279 | -3,534 | -3,179 | -3,758 |
| Financing Cash Flow | $-3,283 | $-3,279 | $-3,534 | $-3,179 | $-3,758 |
| Exchange Rate Effect | 838 | -295 | 48 | 294 | -359 |
| Beginning Cash Position | 28,581 | 26,545 | 30,874 | 28,410 | 27,265 |
| End Cash Position | 31,259 | 28,581 | 26,545 | 30,874 | 28,410 |
| Net Cash Flow | $1,840 | $2,331 | $-4,377 | $2,170 | $1,504 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,177 | 5,654 | -807 | 5,516 | 5,461 |
| Capital Expenditure | -54 | -44 | -36 | -167 | -199 |
| Free Cash Flow | 5,123 | 5,610 | -843 | 5,349 | 5,262 |